These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 32312493)
1. Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors. Oren O; Yang EH; Molina JR; Bailey KR; Blumenthal RS; Kopecky SL Am J Cardiol; 2020 Jun; 125(12):1920-1926. PubMed ID: 32312493 [TBL] [Abstract][Full Text] [Related]
2. Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study. Wan G; Khattab S; Leung BW; Zhang S; Nguyen N; Tran M; Lin C; Chang C; Alexander N; Jairath R; Phillipps J; Tang K; Rajeh A; Zubiri L; Chen ST; Demehri S; Yu KH; Gusev A; Kwatra SG; LeBoeuf NR; Reynolds KL; Semenov YR Br J Dermatol; 2024 Jun; 191(1):117-124. PubMed ID: 38366637 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States. Jain P; Gutierrez Bugarin J; Guha A; Jain C; Patil N; Shen T; Stanevich I; Nikore V; Margolin K; Ernstoff M; Velcheti V; Barnholtz-Sloan J; Dowlati A ESMO Open; 2021 Oct; 6(5):100252. PubMed ID: 34461483 [TBL] [Abstract][Full Text] [Related]
4. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071 [TBL] [Abstract][Full Text] [Related]
5. Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database. Kuo HT; Chen CY; Hsu AY; Wang YH; Lin CJ; Hsia NY; Tsai YY; Wei JC Front Immunol; 2023; 14():1302293. PubMed ID: 38264654 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular toxicity in patients treated with immunotherapy for metastatic non-small cell lung cancer: A SEER-medicare study: CVD outcomes with the use of ICI in mNSCLC. Bishnoi R; Shah C; Blaes A; Bian J; Hong YR Lung Cancer; 2020 Dec; 150():172-177. PubMed ID: 33186859 [TBL] [Abstract][Full Text] [Related]
7. Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy. Schiffer WB; Deych E; Lenihan DJ; Zhang KW Int J Cardiol; 2021 Jan; 322():177-182. PubMed ID: 32800916 [TBL] [Abstract][Full Text] [Related]
8. Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer. Li M; Spakowicz D; Zhao S; Patel SH; Johns A; Grogan M; Miah A; Husain M; He K; Bertino EM; Shields PG; Wei L; Carbone DP; Otterson GA; Presley CJ; Owen DH Cancer Immunol Immunother; 2020 Nov; 69(11):2403-2408. PubMed ID: 32728772 [TBL] [Abstract][Full Text] [Related]
19. THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPY. Ivanovic M; Chan A; Cheng E; Xu S; Lee C; You J; Franquiz M; Fazal M; Batchelder R; Wu SM; Reddy SA; Katsumoto T; Ramchandran K; Colevas AD; Khan SA; Fan AC; Cheng P; Wakelee H; Witteles R; Neal JW; Waliany S; Zhu H medRxiv; 2024 Jan; ():. PubMed ID: 38343840 [TBL] [Abstract][Full Text] [Related]
20. Association Between Socioeconomic Status and Mortality, Cardiovascular Disease, and Cancer in Patients With Type 2 Diabetes. Rawshani A; Svensson AM; Zethelius B; Eliasson B; Rosengren A; Gudbjörnsdottir S JAMA Intern Med; 2016 Aug; 176(8):1146-54. PubMed ID: 27367969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]